How successful is medicare advantage?

Milbank Quarterly

Volumn 92, Issue 2, 2014, Pages 351-394

  Newhouse, Joseph P ^a,b,c,d   McGuire, Thomas G ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD UNIVERSITY   (United States)

^d NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

health care costs; managed care; Medicare; payment policy

Indexed keywords

ARTICLE; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; MEDICARE; PRIORITY JOURNAL;

HEALTH CARE COSTS; MANAGED CARE; MEDICARE; PAYMENT POLICY;

HEALTH CARE COSTS; HEALTH POLICY; HUMANS; MEDICARE PART C; PATIENT PREFERENCE; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 84901946961     PISSN: 0887378X     EISSN: 14680009     Source Type: Journal    
DOI: 10.1111/1468-0009.12061     Document Type: Article

References (66)

1. McGuire TG, Newhouse JP, Sinaiko AD,. A history of Medicare Part C. Milbank Q. 2011; 89 (2): 289-332.
2. Gold M, Jacobson G, D'Amico A, Neuman T,. Medicare Advantage 2013 spotlight: enrollment market update. http://kaiserfamilyfoundation.files. wordpress.com/2013/06/8448.pdf. Published June 2013. Accessed September 7, 2013.
3. Centers for Medicare and Medicaid Services. CMS fast facts. http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and- Reports/CMS-Fast-Facts/index.html. Updated January 15, 2014. Accessed February 5, 2014.
4. Eggers P,. Risk differential between Medicare beneficiaries enrolled and not enrolled in an HMO. Health Care Finance Rev. 1980; 1 (3): 91-99.
5. Eggers P, Prihoda R,. Pre-enrollment reimbursement patterns of Medicare beneficiaries enrolled in "at-risk" HMOs. Health Care Finance Rev. 1982; 4 (1): 55-73.
6. Langwell KM, Hadley JP,. Evaluation of the Medicare competition demonstrations. Health Care Finance Rev. 1989; 11 (2): 65-80.
7. Brown RS, Bergeron JW, Clement DG, Hill JW, Retchin SM,. The Medicare Risk Program for HMOs-Final Summary Report on Findings from the Evaluation. Princeton, NJ: Mathematica Policy Research, Inc; 1993.
8. Brown RS, Clement DG, Hill JW, Retchin SM, Bergeron JW,. Do health maintenance organizations work for Medicare ? Health Care Finance Rev. 1993; 15 (1): 7-23.
9. Cutler DM, Zeckhauser RJ,. The anatomy of health insurance. In:, Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Amsterdam, the Netherlands: North-Holland; 2000: 563-644.
10. Glied SA,. Managed care. In:, Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Amsterdam, the Netherlands: North-Holland; 2000: 707-753.
11. van de Ven WPMM, Ellis RP,. Risk adjustment in competitive health plan markets. In:, Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Amsterdam, the Netherlands: North-Holland; 2000: 755-846.
12. Breyer FM, Bundorf K, Pauly MV,. Health care spending risk, health insurance, and payment to health plans. In:, Pauly MV, McGuire TG, Barros PP, eds. Handbook of Health Economics. Amsterdam, the Netherlands: North-Holland; 2012: 691-762.
13. Medicare Payment Advisory Commission. Report to the Congress: Medicare Payment Policy, March 2004. Washington, DC: Medicare Payment Advisory Commission; 2004.
14. Medicare Payment Advisory Commission. Report to the Congress: Issues in a Modernized Medicare Program, June 2005. Washington, DC: Medicare Payment Advisory Commission; 2005.
15. Medicare Payment Advisory Commission. Report to the Congress: Medicare Payment Policy, March 2007. Washington, DC: Medicare Payment Advisory Commission; 2007.
16. Hellinger FJ,. Commentary-assessing the impact of managed care patient protection laws-problems and pitfalls. Health Serv Res. 2005; 40 (3): 669-674.
17. Baker L,. HMOs and fee for service health care expenditures: evidence from Medicare. J Health Econ. 1997; 16 (4): 453-481.
18. Baker L,. Association of managed care market share and health expenditures for fee-for-service Medicare patients. JAMA. 1999; 281 (5): 432-437.
19. Baker L, Cantor JC, Long SH, Marquis MS,. HMO market penetration and costs of employer-sponsored health plans. Health Aff. 2000; 19 (5): 121-128.
20. Baker L, Corts KS,. HMO penetration and the cost of health care: market discipline or market segmentation ? Am Econ Rev. 1996; 86 (2): 389-394.
21. Baker L, Shankarkumar S,. Managed care and health care expenditures: evidence from Medicare, 1990-1994. Front Health Policy Res. 1998; 1: 117-152.
22. Song Z, Landrum MB, Chernew ME,. Competitive bidding in Medicare: who benefits from competition ? Am J Manag Care. 2012; 18 (9): 546-552.
23. Song Z, Landrum MB, Chernew ME,. Competitive bidding in Medicare Advantage: effect of benchmark changes on plan bids. J Health Econ. 2013; 32 (6): 1301-1312.
24. Abaluck J, Gruber J,. Choice inconsistencies among the elderly: evidence from plan choice in the Medicare Part D program. Am Econ Rev. 2011; 101 (4): 1180-1210.
25. Heiss F, Leive A, McFadden D, Winter J,. Plan selection in Medicare Part D: evidence from administrative data. J Health Econ. 2013; 32 (6): 1325-1344.
26. McWilliams JM, Afendulis CC, McGuire TG, Landon BE,. Complex Medicare Advantage choices may overwhelm seniors-especially those with impaired decision making. Health Aff. 2011; 30 (9): 1786-1794.
27. Sinaiko AD, Afendulis CC, Frank RG,. Enrollment in Medicare Advantage plans in Miami-Dade County: evidence of status quo bias? Cambridge, MA: National Bureau of Economic Research; 2013.
28. Glazer J, McGuire TG,. Making Medicare Advantage a middle class program. J Health Econ. 2013; 31: 463-473.
29. Kaiser Family Foundation, and Health Research and Educational Trust. Employer health benefits: 2013 annual survey. http://kaiserfamilyfoundation. files.wordpress.com/2013/08/8465-employer-health-benefits-20131.pdf. Published August 20, 2013. Accessed February 6, 2014.
30. Iyengar S,. How much choice is too much? Determinants of individual contributions in 401(k) retirement plans. In:, Mitchell OS, Utkus SP, eds. Pension Design and Structure: New Lessons from Behavioral Finance. New York, NY: Oxford University Press; 2004: 83-97.
31. Samuelson W, Zeckhauser RJ,. Status quo bias in decision making. J Risk Insur. 1988; 1 (1): 7-59.
32. Finkelstein A,. EZ-Tax: tax salience and tax rates. Q J Econ. 2009; 124 (3): 969-1010.
33. Einav L, Finkelstein A,. Selection in insurance markets: theory and empirics in pictures. J Econ Perspect. 2011; 25 (1): 115-138.
34. Keeler EB, Carter GM, Newhouse JP,. A model of the impact of reimbursement schemes on health plan choice. J Health Econ. 1998; 17 (3): 297-320.
35. Bundorf MK, Levin J, Mahoney N,. Pricing and welfare in health plan choice. Am Econ Rev. 2012; 102 (7): 3214-3248.
36. Glazer J, McGuire TG,. Gold and silver health plans: accommodating demand heterogeneity in managed competition. J Health Econ. 2011; 30 (5): 1011-1019.
37. Baicker K, Chernew ME, Robbins J,. The spillover effects of Medicare Advantage. J Health Econ. 2013; 32 (6): 1289-1300.
38. Feldman R, Dowd B,. Simulation of a health insurance market with adverse selection. J Oper Res. 1982; 30 (6): 1027-1042.
39. Cutler DM, Reber SJ,. Paying for health insurance: the tradeoff between competition and adverse selection. Q J Econ. 1998; 113 (2): 433-466.
40. Einav L, Finkelstein A, Cullen MR,. Estimating welfare in insurance markets using variation in prices. Q J Econ. 2010; 125 (3): 877-921.
41. Rothschild M, Stiglitz J,. Equilibrium in competitive insurance markets: an essay on the economics of imperfect information. Q J Econ. 1976; 90 (4): 629-650.
42. Newhouse JP, Manning WG, Keeler EB, Sloss EM,. Adjusting capitation rates using objective health measures and prior utilization. Health Care Finance Rev. 1989; 10 (3): 41-54.
43. Medicare Payment Advisory Commission. Report to the Congress: Medicare Payment Policy, March 1998. Washington, DC: Medicare Payment Advisory Commission; 1998.
44. Pope GC, Kautter J, Ellis RP, et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Finance Rev. 2004; 25 (4): 119-141.
45. McWilliams JM, Hsu J, Newhouse JP,. New risk-adjustment system was associated with reduced favorable selection in Medicare Advantage. Health Aff. 2012; 31 (12): 2630-2640.
46. Newhouse JP, Huang J, Price M, McWilliams JM, Hsu J,. Steps to reduce favorable risk selection in Medicare Advantage largely succeeded, boding well for health insurance exchanges. Health Aff. 2012; 31 (12): 2618-2628.
47. Physician Payment Review Commission. Annual Report to Congress, 1996. Washington, DC: Physician Payment Review Commission; 1996.
48. Medicare Payment Advisory Commission. Report to the Congress: Improving Risk Adjustment in Medicare. Washington, DC: Medicare Payment Advisory Commission; 2000.
49. Buntin MB, Garber AM, McClellan M, Newhouse JP,. The cost of decedents in the Medicare program: implications for payments to the Medicare+Choice plans. Health Serv Res. 2004; 39 (1): 111-130.
50. Feinstein AR, Sosin DM, Wells CK,. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985; 312 (25): 1604-1608.
51. Brown J, Duggan M, Kuziemko I, Woolston W,. How does risk selection respond to risk adjustment? Evidence from the Medicare Advantage Program. Cambridge, MA: National Bureau of Economic Research; 2011: Working Paper 16977.
52. Frank RG, Glazer J, McGuire TG,. Measuring adverse selection in managed health care. J Health Econ. 2000; 19 (6): 829-854.
53. McGuire TG, Glazer J, Newhouse JP, et al. Integrating risk adjustment and enrollee premiums in health plan payment. J Health Econ. 2013; 32 (6): 1263-1277.
54. Newhouse JP, McWilliams JM, Price M, Huang J, Fireman B, Hsu J,. Do Medicare Advantage plans select enrollees in higher margin clinical categories? J Health Econ. 2013; 32 (6): 1278-1288.
55. Newhouse JP, Price M, McWilliams JM, Hsu J, McGuire TG,. How Much Favorable Selection Is Left in Medicare Advantage? Cambridge, MA: National Bureau of Economic Research; 2014: Working Paper 10021.
56. Landon BE, Zaslavsky AM, Saunders R, Pawlson LG, Newhouse JP, Ayanian JZ,. Analysis of Medicare Advantage HMOs compared with traditional Medicare shows lower use of many services during 2003-09. Health Aff. 2012; 31 (12): 2609-2617.
57. Ayanian JZ, Landon BE, Zaslavsky AM, Saunders R, Pawlson LG, Newhouse JP,. Medicare beneficiaries more likely to receive appropriate ambulatory services in HMOs than in traditional Medicare. Health Aff. 2013; 32 (7): 1228-1235.
58. Ayanian JZ, Landon BE, Zaslavsky AM, Newhouse, JP,. Racial and ethnic differences in breast cancer screening in Medicare Advantage and traditional Medicare. J Natl Cancer Inst. 2013; 105 (24): 1891-1896.
59. Stevenson DG, Ayanian JZ, Zaslavsky AM, Newhouse JP, Landon BE,. Service use at the end-of-life in Medicare Advantage versus traditional Medicare. Med Care. 2013; 51 (10): 931-937.
60. Dafny, L., Are health insurance markets competitive? Am Econ Rev. 2010; 100 (4): 1399-1431.
61. Dafny L, Duggan M, Ramanrayanan S,. Paying a premium on your premium? Consolidation in the U.S. health insurance industry. Am Econ Rev. 2012; 102 (2): 1161-1185.
62. Dranove D., Health care markets, regulators, and certifiers. In:, Pauly MV, McGuire TG, Barros PP, eds. Handbook of Health Economics. Amsterdam, the Netherlands: North-Holland; 2012: 639-690.
63. Gaynor M, Town RJ,. Competition in health care markets. In:, Pauly MV, McGuire TG, Barros PP, eds. Handbook of Health Economics. Amsterdam, the Netherlands: North-Holland; 2012: 499-637.
64. Enthoven AC., Theory and Practice of Managed Care Competition in Health Care Finance. Amsterdam, the Netherlands: North-Holland; 1988.
65. Medicare Payment Advisory Commission. Report to the Congress: Medicare and the Health Care Delivery System. Washington, DC: Medicare Payment Advisory Commission; 2013.
66. McDonough JE., Inside National Health Reform. Berkeley CA; New York, NY: University of California Press and Milbank Memorial Fund; 2011.